NCT05607745 - DIFTOB - Fecal Microbiota Transplantation (FMT) & Adiposity / Obesity and Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Study overview

It is a randomized basic science clinical trial studying Fecal Microbiota Transplantation (FMT) or placebo in patients with Adiposity / Obesity and/or Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Primary outcome measures

A change in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)

Results

There are no published results as of March 2026